Kalm Therapeutics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Kalm Therapeutics Inc. - overview
Established
2022
Location
Huntsville, AL, US
Primary Industry
Healthcare Specialists
About
Based in Alabama, US, and founded in 2022 by CTO AJ Singhal, Kalm Therapeutics Inc. , a. k. a.
Kalm Therapeutics operates as a pharmaceutical development company that produces The Kalm Patch, which treats psoriasis and dermatitis in patients. In August 2024, Kalm Therapeutics Inc. raised USD 0. 7 million in seed funding.
As of August 2024, Chis Seibert is the CEO of the company. Kalm Therapeutics is developing a prescription patch for eczema and psoriasis treatment. The Kalm Patch protects affected skin from scratching, infection, and moisture loss while delivering a continuous therapeutic dose over 24 hours. The patch uses a plant-based, anti-inflammatory ingredient and is applied once daily, offering a safer alternative to traditional steroids and creams.
The product is designed to treat multiple common skin conditions with a single candidate, providing treatment with minimal intervention. The company plans to use its proceeds from August 2024 funding to assist with regulatory actions, provide funding for staff, and hand off patch production to the manufacturer.
Current Investors
Innovate Alabama
Primary Industry
Healthcare Specialists
Sub Industries
Biopharmaceuticals, Dermatology
Website
www.kalmtherapeutics.com
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.